Alzamend Neuro Inc(NASDAQ:ALZN) 
Alzamend Neuro is preclinical stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. With our two current and future product candidates, we aim to bring treatments or cures to market at a reasonable cost as quic...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 9.18
H 9.45
L 8.46
C 8.82
V 106,270
10EMA 8.82
20EMA 8.82
60EMA 8.82
120EMA 8.82
250EMA 8.82